Steuer CE - Search Results

1

Atypical carcinoid tumor of the lung: a surveillance, epidemiology, and end results database analysis.

Steuer CE, Behera M, Kim S, Chen Z, Saba NF, Pillai RN, Owonikoko TK, Khuri FR, Ramalingam SS. Steuer CE, et al. J Thorac Oncol. 2015 Mar;10(3):479-85. doi: 10.1097/JTO.0000000000000419. J Thorac Oncol. 2015. PMID: 25371080 Free article.

2

Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.

Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.

3

ALK-positive non-small cell lung cancer: mechanisms of resistance and emerging treatment options.

Steuer CE, Ramalingam SS. Steuer CE, et al. Cancer. 2014 Aug 15;120(16):2392-402. doi: 10.1002/cncr.28597. Epub 2014 May 22. Cancer. 2014. PMID: 24853389 Free article. Review.

4

The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancer.

Steuer CE, Khuri FR, Ramalingam SS. Steuer CE, et al. Cancer. 2015 Apr 15;121(8):E1-6. doi: 10.1002/cncr.29139. Epub 2014 Dec 17. Cancer. 2015. PMID: 25521095 Free article. Review.

5

Innovative Clinical Trials: The LUNG-MAP Study.

Steuer CE, Papadimitrakopoulou V, Herbst RS, Redman MW, Hirsch FR, Mack PC, Ramalingam SS, Gandara DR. Steuer CE, et al. Clin Pharmacol Ther. 2015 May;97(5):488-91. doi: 10.1002/cpt.88. Clin Pharmacol Ther. 2015. PMID: 25676724 Review.

6

Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis.

Steuer CE, Behera M, Kim S, Patel N, Chen Z, Pillai R, Saba NF, Shin DM, Owonikoko TK, Khuri FR, Ramalingam SS. Steuer CE, et al. Lung Cancer. 2015 Apr;88(1):80-4. doi: 10.1016/j.lungcan.2015.01.022. Epub 2015 Feb 2. Lung Cancer. 2015. PMID: 25726042

7

Targeting EGFR in lung cancer: Lessons learned and future perspectives.

Steuer CE, Ramalingam SS. Steuer CE, et al. Mol Aspects Med. 2015 Nov;45:67-73. doi: 10.1016/j.mam.2015.05.004. Epub 2015 May 27. Mol Aspects Med. 2015. PMID: 26022942 Free PMC article. Review.

8

Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Systematic Review.

Behera M, Pillai RN, Owonikoko TK, Kim S, Steuer C, Chen Z, Saba NF, Belani CP, Khuri FR, Ramalingam SS. Behera M, et al. J Thorac Oncol. 2015 Aug;10(8):1142-7. doi: 10.1097/JTO.0000000000000572. J Thorac Oncol. 2015. PMID: 26200267 Free article. Review.

9

Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005.

Behera M, Ragin C, Kim S, Pillai RN, Chen Z, Steuer CE, Saba NF, Belani CP, Khuri FR, Ramalingam SS, Owonikoko TK. Behera M, et al. Among authors: steuer ce. Cancer. 2016 Jan 1;122(1):50-60. doi: 10.1002/cncr.29674. Epub 2015 Oct 6. Cancer. 2016. PMID: 26441041 Free PMC article.

10

Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy.

McKibbin T, Cheng LL, Kim S, Steuer CE, Owonikoko TK, Khuri FR, Shin DM, Saba NF. McKibbin T, et al. Among authors: steuer ce. Support Care Cancer. 2016 Apr;24(4):1789-93. doi: 10.1007/s00520-015-2978-0. Epub 2015 Oct 7. Support Care Cancer. 2016. PMID: 26446698

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters